Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus (original) (raw)

Nature volume 394, pages 588–592 (1998)Cite this article

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is invariably present in Kaposi's sarcoma lesions1,2. KSHV contains several viral oncogenes and serological evidence suggests that KSHV infection is necessary for the development of Kaposi's sarcoma, but cellular transformation by this virus has not so far been demonstrated. KSHV is found in the microvascular endothelial cells in Kaposi's sarcoma lesions and in the spindle ‘tumour’ cells3,4, which are also thought to be of endothelial origin. Here we investigate the biological consequences of infecting human primary endothelial cells with purified KSHV particles. We find that infection causes long-term proliferation and survival of these cells, which are associated with the acquisition of telomerase activity and anchorage-independent growth. KSHV was present in only a subset of cells, and paracrine mechanisms were found to be responsible for the survival of uninfected cells. Their survival may have been mediated by upregulation of a receptor for vascular endothelial growth factor. Our results indicate that transformation of endothelial cells by KSHV, as well as paracrine mechanisms that are induced by this virus, may be critical in the pathogenesis of Kaposi's sarcoma.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869 (1994).
    Article ADS CAS Google Scholar
  2. Moore, P. S. & Chang, Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N. Engl. J. Med. 332, 1181–1185 (1995).
    Article CAS Google Scholar
  3. Boshoff, C. et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med. 1, 1274–1278 (1995).
    Article CAS Google Scholar
  4. Reed, J. A. et al. Demonstration of Kaposi's sarcoma-associated herpesvirus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood(in the press).
  5. Arvanitakis, L. et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein–Barr virus. Blood 88, 2648–2654 (1996).
    CAS PubMed Google Scholar
  6. Renne, R. et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med. 2, 342–346 (1996).
    Article CAS Google Scholar
  7. Miller, G. et al. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71, 314–324 (1997).
    CAS PubMed PubMed Central Google Scholar
  8. Rafii, S. et al. Human bone marrow microvascular endothelial support long term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86, 3353–3363 (1995).
    CAS PubMed Google Scholar
  9. Watanabe, Y. & Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced aposptosis in microvessel endothelial cells by inducing scaffold formation. Exp. Cell Res. 233, 340–349 (1997).
    Article CAS Google Scholar
  10. Cesarman, E. et al. Kaposi's sarcoma associated herpesvirus (KSHV/HHV-8) contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70, 8218–8223 (1996).
    CAS PubMed PubMed Central Google Scholar
  11. O'Leary, J. PCR In-situ Hybridization. 1–53-86 (IRL, Oxford University Press, Oxford, (1997)).
    Google Scholar
  12. Ruby Chan, S., Bloomer, C. & Chandran, B. Identification and characterization of human herpesvirus-8 lytic cycle associated ORF 59 protein and the encoding cDNA by monoclonal antibody. Virology 240, 118–126 (1998).
    Article Google Scholar
  13. Hewett, P. W. & Murray, J. C. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochem. Biophys. Res. Commun. 221, 697–702 (1996).
    Article CAS Google Scholar
  14. Rienke, U., Burlington, H., Cronkite, E. P. & Laissue, J. Hayflick's hypothesis: an approach to in vivo testing. Fed. Proc. 34, 71–75 (1975).
    Google Scholar
  15. Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
    Article ADS CAS Google Scholar
  16. Mieczyslaw, A. P. et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Meth. Cell Sci. 17, 1–15 (1995).
    Article Google Scholar
  17. Kennedy, M. M. et al. HHV8 and Kaposi's sarcoma: a time cohort study. Mol. Pathol. 50, 96–100 (1997).
    Article CAS Google Scholar
  18. Rhoads, R. E. Optimization of the annealing temperature for DNA amplification in vitro. Nucleic Acids Res. 18, 6409–6412 (1990).
    Article Google Scholar
  19. Kedes, D. H. et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med. 2, 918–924 (1996).
    Article CAS Google Scholar
  20. Kim, N. W. & Wu, F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595–2597 (1997).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank S. Chen-Kiang, D. Knowles, M. C. Gershengorn and E. Mesri for their suggestions; B. Chandran and S.-J. Gao for antibodies against lytic antigens; P. Pellet for positive controls CMB and HHV-6; L. Friedman, S. Nikolovska, B. Ferris, G. Lam, A. J. Naiyer, S. Diana, I. Silva and V.Uhlmann for technical help; and S. Picton and K. Lohman at Perkin Elmer Applied Biosystems.

Author information

Authors and Affiliations

  1. Department of Pathology, Department of Medicine, Cornell University Medical College, New York, 10021, New York, USA
    Ornella Flore, Scott Ely, John J. O'Leary, Elizabeth M. Hyjek & Ethel Cesarman
  2. Department of Pathology, Division of Hematology-Oncology, Department of Medicine, Cornell University Medical College, New York, 10021, New York, USA
    Shahin Rafii
  3. Dipartimento di Medicina Interna, Universita' di Cagliari, Cagliari, 09100, Italy
    Ornella Flore
  4. Departments of Pathology, The Coombe Women's Hospital and St James's Hospital Dublin, and Trinity College Dublin, Ireland
    John J. O'Leary

Authors

  1. Ornella Flore
    You can also search for this author inPubMed Google Scholar
  2. Shahin Rafii
    You can also search for this author inPubMed Google Scholar
  3. Scott Ely
    You can also search for this author inPubMed Google Scholar
  4. John J. O'Leary
    You can also search for this author inPubMed Google Scholar
  5. Elizabeth M. Hyjek
    You can also search for this author inPubMed Google Scholar
  6. Ethel Cesarman
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toEthel Cesarman.

Supplementary Information

Rights and permissions

About this article

Cite this article

Flore, O., Rafii, S., Ely, S. et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.Nature 394, 588–592 (1998). https://doi.org/10.1038/29093

Download citation

This article is cited by